Mesa Laboratories Inc (MLAB)

Name: Mesa Laboratories Inc Financial Statements
Creator: Quarter Results

Technology | Hardware Equipment Parts

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$65.1M

Net Income

$3.6M

Operating Margin

12.2%

Free Cash Flow

$42.3M

Debt / Assets

63.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Mesa Laboratories Inc (MLAB).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2024-12-31
Revenue	65,126,000	60,737,000	59,543,000	62,840,000
Cost of Revenue	23,331,000	23,406,000	27,049,000	23,086,000
Gross Profit	41,795,000	37,331,000	32,494,000	39,754,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	28,791,000	27,559,000	28,891,000	28,922,000
Operating Expenses	33,820,000	32,607,000	29,430,000	33,975,000
Operating Income	7,975,000	4,724,000	3,064,000	5,779,000
Interest Expense	3,036,000	2,862,000	2,198,000	2,842,000
Income Before Tax	4,596,000	1,999,000	7,012,000	-2,217,000
Income Tax Expense	966,000	-477,000	2,270,000	-541,000
Net Income	3,630,000	2,476,000	4,742,000	-1,676,000
Per Share
EPS	0.66	0.45	0.87	-0.31
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Mesa Laboratories Inc (MLAB).
Income Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Revenue	240,978,000	216,187,000	219,080,000	184,335,000	133,937,000
Cost of Revenue	90,108,000	82,937,000	85,387,000	75,245,000	46,923,000
Gross Profit	150,870,000	133,250,000	133,693,000	109,090,000	87,014,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	115,016,000	111,492,000	109,883,000	88,621,000	64,177,000
Operating Expenses	134,534,000	406,554,000	130,373,000	104,388,000	74,565,000
Operating Income	16,336,000	-272,075,000	-30,504,000	-20,366,000	12,358,000
Interest Expense	11,859,000	5,697,000	3,709,000	3,885,000	8,024,000
Income Before Tax	5,961,000	-275,648,000	-389,000	3,574,000	2,303,000
Income Tax Expense	7,935,000	-21,402,000	-1,319,000	1,703,000	-971,000
Net Income	-1,974,000	-254,246,000	930,000	1,871,000	3,274,000
Per Share
EPS	-0.36	-47.20	0.17	0.36	0.66
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Mesa Laboratories Inc (MLAB).
Balance Sheet (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Assets
Cash and Cash Equivalents	27,321,000	28,214,000	32,910,000	49,346,000
Short Term Investments	0	0	0	0
Net Receivables	41,970,000	39,055,000	42,551,000	41,224,000
Inventory	25,365,000	32,675,000	34,642,000	24,606,000
Total Current Assets	102,685,000	109,352,000	118,975,000	124,318,000
Property Plant Equipment	32,333,000	41,437,000	28,149,000	28,620,000
Goodwill and Intangibles	278,635,000	293,848,000	304,670,000	541,283,000
Total Assets	433,348,000	446,796,000	661,832,000	707,369,000
Liabilities
Account Payables	5,747,000	6,041,000	6,134,000	7,897,000
Short Term Debt	104,570,000	2,986,000	2,868,000	2,768,000
Total Current Liabilities	163,963,000	44,312,000	43,359,000	48,055,000
Long Term Debt	76,902,000	228,311,000	170,272,000	218,365,000
Total Liabilities	273,518,000	301,403,000	268,352,000	313,568,000
Shareholders Equity
Retained Earnings	-188,936,000	-183,494,000	74,199,000	76,675,000
Total Shareholders Equity	159,830,000	145,393,000	393,480,000	393,801,000

Balance sheet annual history for Mesa Laboratories Inc (MLAB).
Balance Sheet (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Assets
Cash and Cash Equivalents	27,321,000	28,214,000	32,910,000	49,346,000	263,865,000
Short Term Investments	0	0	0	0	0
Net Receivables	41,970,000	39,055,000	42,551,000	41,224,000	23,787,000
Inventory	25,365,000	32,675,000	34,642,000	24,606,000	11,178,000
Total Current Assets	102,685,000	109,352,000	118,975,000	124,318,000	303,749,000
Property Plant Equipment	32,333,000	41,437,000	28,149,000	28,620,000	21,998,000
Goodwill and Intangibles	278,635,000	293,848,000	304,670,000	541,283,000	272,582,000
Total Assets	433,348,000	446,796,000	661,832,000	707,369,000	601,475,000
Liabilities
Account Payables	5,747,000	6,041,000	6,134,000	7,897,000	4,473,000
Short Term Debt	104,570,000	2,986,000	2,868,000	2,768,000	1,023,000
Total Current Liabilities	163,963,000	44,312,000	43,359,000	48,055,000	32,583,000
Long Term Debt	76,902,000	228,311,000	170,272,000	218,365,000	145,675,000
Total Liabilities	273,518,000	301,403,000	268,352,000	313,568,000	195,248,000
Shareholders Equity
Retained Earnings	-188,936,000	-183,494,000	74,199,000	76,675,000	72,459,000
Total Shareholders Equity	159,830,000	145,393,000	393,480,000	393,801,000	406,227,000

Cash flow quarterly history for Mesa Laboratories Inc (MLAB).
Cash Flow Statement (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Operating Activities
Net Income	-1,974,000	-254,246,000	930,000	1,871,000
Depreciation & Amortization	24,527,000	31,574,000	33,824,000	25,068,000
Stock Based Compensation	13,142,000	11,936,000	12,538,000	11,391,000
Change in Working Capital	6,904,000	5,973,000	-17,112,000	-7,192,000
Operating Cash Flow	46,808,000	44,133,000	27,983,000	39,223,000
Investing Activities
Capital Expenditure	-4,499,000	-2,567,000	-4,544,000	-4,432,000
Investments	-4,249,000	-2,567,000	-4,544,000	-4,432,000
Investing Cash Flow	-4,499,000	-81,306,000	-9,494,000	-305,225,000
Financing Activities
Debt Repayment	-42,346,000	37,500,000	-36,000,000	-21,000,000
Common Stock Issued/Repurchased	0	0	6,078,000	6,277,000
Dividends Paid	-3,468,000	-3,447,000	-3,406,000	-3,339,000
Financing Cash Flow	-44,509,000	32,836,000	-33,328,000	52,576,000
Summary
Free Cash Flow	42,309,000	41,566,000	23,439,000	34,791,000
Net Change in Cash	-893,000	-4,696,000	-16,436,000	-214,519,000

Cash flow annual history for Mesa Laboratories Inc (MLAB).
Cash Flow Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Operating Activities
Net Income	-1,974,000	-254,246,000	930,000	1,871,000	3,274,000
Depreciation & Amortization	24,527,000	31,574,000	33,824,000	25,068,000	17,660,000
Stock Based Compensation	13,142,000	11,936,000	12,538,000	11,391,000	9,268,000
Change in Working Capital	6,904,000	5,973,000	-17,112,000	-7,192,000	5,252,000
Operating Cash Flow	46,808,000	44,133,000	27,983,000	39,223,000	37,073,000
Investing Activities
Capital Expenditure	-4,499,000	-2,567,000	-4,544,000	-4,432,000	-1,992,000
Investments	-4,249,000	-2,567,000	-4,544,000	-4,432,000	-1,992,000
Investing Cash Flow	-4,499,000	-81,306,000	-9,494,000	-305,225,000	-1,992,000
Financing Activities
Debt Repayment	-42,346,000	37,500,000	-36,000,000	-21,000,000	0
Common Stock Issued/Repurchased	0	0	6,078,000	6,277,000	145,935,000
Dividends Paid	-3,468,000	-3,447,000	-3,406,000	-3,339,000	-3,165,000
Financing Cash Flow	-44,509,000	32,836,000	-33,328,000	52,576,000	146,228,000
Summary
Free Cash Flow	42,309,000	41,566,000	23,439,000	34,791,000	35,081,000
Net Change in Cash	-893,000	-4,696,000	-16,436,000	-214,519,000	182,485,000